BRAIN; Christopher Thomas
Patent Applications and Registrations
Patent applications and USPTO patent grants for BRAIN; Christopher Thomas.The latest application filed is for "pyrrolopyrimidine compounds and their uses".
Company Profile
0.22.35
- BRAIN; Christopher Thomas - North Reading MA
- Brain; Christopher Thomas - Cambridge MA
- Brain; Christopher Thomas - Horsham GB
- Brain; Christopher Thomas - West Sussex GB
- Brain; Christopher Thomas - London GB
Patent Activity
| Patent | Date |
|---|---|
| Pyrrolopyrimidine Compounds And Their Uses App 20210253578 - BESONG; Gilbert ; et al. | 2021-08-19 |
| Methods and compositions for treating solid tumors and other malignancies App 20180207163 - Borland; Maria ; et al. | 2018-07-26 |
| Pyrrolopyrimidine Compounds And Their Uses App 20180155351 - Besong; Gilbert ; et al. | 2018-06-07 |
| Pyrrolopyrimidine Compounds And Their Uses App 20170183352 - BESONG; Gilbert ; et al. | 2017-06-29 |
| Pyrrolopyrimidine compounds and their uses Grant 9,416,136 - Besong , et al. August 16, 2 | 2016-08-16 |
| Pyrrolopyrimidine compounds as inhibitors of CDK4/6 Grant 9,309,252 - Brain , et al. April 12, 2 | 2016-04-12 |
| Combination Comprising a Cyclin Dependent Kinase 4 or Cyclin Dependent Kinase (CDK4/6) Inhibitor for Treating Cancer App 20160008367 - Borland; Maria ; et al. | 2016-01-14 |
| Substituted quinazolinones as vanilloid antagonists Grant 9,102,653 - Ritchie , et al. August 11, 2 | 2015-08-11 |
| Pyrrolopyrimidine Compounds As Inhibitors Of Cdk4/6 App 20150099737 - BRAIN; Christopher Thomas ; et al. | 2015-04-09 |
| Pyrrolopyrimidine compounds and their uses Grant 8,962,630 - Brain , et al. February 24, 2 | 2015-02-24 |
| Pyrrolopyrimidine compounds as inhibitors of CDK4/6 Grant 8,957,074 - Brain , et al. February 17, 2 | 2015-02-17 |
| Quinazolinone Derivatives Useful As Vanilloid Antagonists App 20140315932 - RITCHIE; Timothy John ; et al. | 2014-10-23 |
| Quinazolinone derivatives useful as vanilloid antagonists Grant 8,809,528 - Ritchie , et al. August 19, 2 | 2014-08-19 |
| Pyrrolopyrimidine Compounds And Their Uses App 20140135312 - BESONG; Gilbert ; et al. | 2014-05-15 |
| Pyrrolopyrimidine compounds and their uses Grant 8,685,980 - Besong , et al. April 1, 2 | 2014-04-01 |
| Imidazole derivatives and their use as modulators of cyclin dependent kinases Grant 8,598,217 - Howard , et al. December 3, 2 | 2013-12-03 |
| Deuterated Pyrrolopyrimidine Compounds As Inhibitors Of Cdk4/6 App 20130203765 - Brain; Christopher Thomas ; et al. | 2013-08-08 |
| Pyrrolopyrimidine Compounds And Their Uses App 20130184285 - BRAIN; Christopher Thomas ; et al. | 2013-07-18 |
| Pyrrolopyrimidine Compounds As Inhibitors Of Cdk4/6 App 20130150342 - Brain; Christopher Thomas ; et al. | 2013-06-13 |
| Pyrrolopyrimidine compounds and their uses Grant 8,415,355 - Brain , et al. April 9, 2 | 2013-04-09 |
| Combination Comprising A Cyclin Dependent Kinase 4 Or Cyclin Dependent Kinase (cdk4/6) Inhibitor For Treating Cancer App 20130035336 - Borland; Maria ; et al. | 2013-02-07 |
| Pyrazole derivatives Grant 8,367,687 - Brain , et al. February 5, 2 | 2013-02-05 |
| Pyrrolopyrimidine compounds and their uses Grant 8,324,225 - Brain , et al. December 4, 2 | 2012-12-04 |
| Pyrrolopyrimidine Compounds And Their Uses App 20120207763 - BRAIN; Christopher Thomas ; et al. | 2012-08-16 |
| Quinazolinone Derivatives Useful As Vanilloid Antagonists App 20120184571 - RITCHIE; Timothy John ; et al. | 2012-07-19 |
| Quinazolinone derivatives useful as vanilloid antagonists Grant 8,211,902 - Ritchie , et al. July 3, 2 | 2012-07-03 |
| Imidazole Derivatives And Their Use As Modulators Of Cyclin Dependent Kinases App 20120101064 - Howard; Steven ; et al. | 2012-04-26 |
| Quinazolinone Derivatives Useful As Vanilloid Antagonists App 20110195983 - Ritchie; Timothy John ; et al. | 2011-08-11 |
| Pyrrolopyrimidine Compounds And Their Uses App 20110152244 - Besong; Gilbert ; et al. | 2011-06-23 |
| Pyrazole Derivatives App 20100280033 - Brain; Christopher Thomas ; et al. | 2010-11-04 |
| Chromone derivatives useful as antagonists of VR1 receptors Grant 7,732,435 - Culshaw , et al. June 8, 2 | 2010-06-08 |
| Pyrrolopyrimidine Compounds And Their Uses App 20100105653 - Besong; Gilbert ; et al. | 2010-04-29 |
| Pyrrolopyrimidine Compounds and Their Uses App 20090318441 - Brain; Christopher Thomas ; et al. | 2009-12-24 |
| Trisubstituted Quinazolinone Derivatives as Vanilloid Antagonists App 20090082365 - Bhalay; Gurdip ; et al. | 2009-03-26 |
| Quinazolinone Derivatives as Vanilloid Antagonists App 20080318940 - Dziadulewicz; Edward Karol ; et al. | 2008-12-25 |
| Chromone Derivatives Useful as Antagonists of Vr1 Receptors App 20080312316 - Culshaw; Andrew James ; et al. | 2008-12-18 |
| Quinazolinone Derivatives Useful as Vanilloid Antagonists App 20080194595 - Ritchie; Timothy John ; et al. | 2008-08-14 |
| Chromone Derivatives Useful as Vanilloid Antagonists App 20080114056 - Ritchie; Timothy John ; et al. | 2008-05-15 |
| Quinazolinone derivatives and their use as CB agonists App 20070265285 - Brain; Christopher Thomas ; et al. | 2007-11-15 |
| Bradykinin receptor antagonists Grant 6,958,331 - Brain , et al. October 25, 2 | 2005-10-25 |
| Quinazolinone derivatives and their use as cb agonists App 20050085493 - Brain, Christopher Thomas ; et al. | 2005-04-21 |
| Naphthalene derivatives App 20040053890 - Brain, Christopher Thomas ; et al. | 2004-03-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 